A trial to assess the effectiveness of Therapeutic Nursing Interventions and Vitamin D3 Supplementation on Blood Glucose and Quality of Life among Geriatric Patients with Type II Diabetes Mellitus - A Randomized Controlled Trial.

A Randomized Controlled single blinded clinical Trial to asess Therapeutic Nursing Interventions and Vitamin D3 Supplementation on Blood Glucose and Quality of Life among Geriatric Patients with Type II Diabetes Mellitus. - TNIVDS

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063255

Enrollment

200

Registered

2024-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Therapeutic Nursing Interventions and Vitamin D3 Supplementation: Therapeutic Nursing Interventions on diabetic diet, drugs, exercises and Vitamin D3600iu will supplement to Geriatric P

Eligibility

Inclusion criteria

Inclusion criteria: 1. Geriatric patients with Type II Diabetes mellitus who have above the age 60 years and within 80 years, both and female. 2. Geriatric patients with normal level of serum vitamin d3, Calcium and phosphorus.(For both sexes, the normal reference ranges for serum Ca 2.12 to 2.65 mmol/L (8.5 to 10.6 mg/dL) and Serum Phosphorus 0.81 to 1.65 mmol/L (2.5 to 5.1 mg/dL, Vitamin D3 is 50 nmol/L (20 ng/mL)), 3. Geriatric patients with Type II Diabetes mellitus who are willing to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Geriatric patients with Type II Diabetes mellitus with other systemic illness like cardiac problem, kidney disease. 2. Geriatric patients with high level of serum vitamin d3, Calcium and phosphorus.(more than serum Ca 2.12 to 2.65 mmol/L (8.5 to 10.6 mg/dL) and Serum Phosphorus 0.81 to 1.65 mmol/L (2.5 to 5.1 mg/dL, Vitamin D3 is 50 nmol/L (20 ng/mL) 3. Not present at the time of data collection.

Design outcomes

Primary

Measure	Time frame
1. REDUCTION IN POST TEST BLOOD GLUCOSE LEVEL. 2. Improvement in Quallity of life among Geriatric Patients with Type II Diabetes mellitus.Timepoint: 10 weeks	—

Secondary

Measure	Time frame
Self awreneess to improve quality of life and blood glucose level among Geriatric patients with Type II Diabetes mellitus.Timepoint: life long	—

Countries

India

Contacts

Public ContactPoongodiI C

Chengalpattu Medical College

chemdean006@gmail.com9443154246

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026